A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients (Q39543582)
Jump to navigation
Jump to search
scientific article published on 29 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients |
scientific article published on 29 July 2016 |
Statements
1 reference
A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients (English)
1 reference
Marcelo E Bigal
1 reference
Dikla Gutman
1 reference
Edward Hellriegel
1 reference
Ernesto Aycardi
1 reference
Jeevan Kunta
1 reference
Rohini Chitra
1 reference
Sujay Kansagra
1 reference
Orna Srur Kidron
1 reference
Helena Knebel
1 reference
Steven Linder
1 reference
Yuju Ma
1 reference
Mark Pierce
1 reference
Paul K Winner
1 reference
Ofer Spiegelstein
1 reference
29 July 2016
1 reference
1 reference
56
1 reference
8
1 reference
1300-1309
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference